We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Generic Prilosec for Mylan and Impax
FDA Approves Generic Prilosec for Mylan and Impax
January 30, 2009
Mylan Pharmaceuticals and Impax Laboratories have received final approval for their ANDAs to market generic versions of AstraZeneca’s heartburn drug Prilosec delayed-release 40-mg capsules.